Evidence map›Paper›PMID 32880638›Full record

ArticleJournal of radiation research2020

Involvement of APOBEC3B in mutation induction by irradiation.

Yohei Saito, Hiromasa Miura, Nozomi Takahashi, Yoshikazu Kuwahara, Yumi Yamamoto, Manabu Fukumoto, Fumihiko Yamamoto

Open access · goldAbstract read
In one paragraph

Article in Journal of radiation research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Clinical Implications of APOBEC3-Mediated Mutagenesis in Breast Cancer.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Yohei SaitoDepartment of Radiopharmacy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Hiromasa MiuraDepartment of Radiopharmacy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Nozomi TakahashiDepartment of Radiopharmacy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Yoshikazu KuwaharaDepartment of Radiation Biology and Medicine, Faculty of Medicine, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Yumi YamamotoDepartment of Radiopharmacy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Manabu FukumotoDepartment of Pathology, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Fumihiko YamamotoDepartment of Radiopharmacy, Tohoku Medical and Pharmaceutical University, Sendai, Japan.
Tohoku Medical and Pharmaceutical University · JPTohoku University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To better understand the cancer risk posed by radiation and the development of radiation therapy resistant cancer cells, we investigated the involvement of the cancer risk factor, APOBEC3B, in the generation of radiation-induced mutations. Expression of APOBEC3B in response to irradiation was determined in three human cancer cell lines by real-time quantitative PCR. Using the hypoxanthine-guanine phosphoribosyl transferase (HPRT) mutation assay, mutations in the HPRT gene caused by irradiation were compared between APOBEC3B-deficient human hepatocellular carcinoma (HepG2) cells [APOBEC3B knocked out (KO) using CRISPR-Cas9 genome editing] and the parent cell line. Then, HPRT-mutated cells were individually cultured to perform PCR and DNA sequencing of HPRT exons. X-Irradiation induced APOBEC3B expression in HepG2, human cervical cancer epithelial carcinoma (HeLa) and human oral squamous cell carcinoma (SAS) cells. Forced expression of APOBEC3B increased spontaneous mutations. By contrast, APOBEC3B KO not only decreased the spontaneous mutation rate, but also strongly suppressed the increase in mutation frequency after irradiation in the parent cell line. Although forced expression of APOBEC3B in the nucleus caused DNA damage, higher levels of APOBEC3B tended to reduce APOBEC3B-induced γ-H2AX foci formation (a measure of DNA damage repair). Further, the number of γ-H2AX foci in cells stably expressing APOBEC3B was not much higher than that in controls before and after irradiation, suggesting that a DNA repair pathway may be activated. This study demonstrates that irradiation induces sustained expression of APOBEC3B in HepG2, HeLa and SAS cells, and that APOBEC3B enhances radiation-induced partial deletions.

Indexed as

DNA RepairMutationCarcinoma, Squamous CellCell Line, TumorCytidine DeaminaseDNA DamageExonsHeLa CellsHep G2 CellsHumansHypoxanthine PhosphoribosyltransferaseMinor Histocompatibility AntigensMouth NeoplasmsMutagenesisPrognosisSequence Analysis, DNAAPOBEC3B protein, humanCytidine DeaminaseHypoxanthine PhosphoribosyltransferaseMinor Histocompatibility AntigensAPOBEC3DNA repairmutation rateradiation effects

Identifiers

PMID32880638
PMCPMC7674755
OpenAlexW3083754107

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.